- Adults (18-64 years)
- Elderly (≥65 years)
- Pregnant women
- Hospital
- Outpatient clinic
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- Pharmacological intervention
- Monoclonal antibodies
- Vaccination
- Nirsevimab
- Abrysvo
Population: Pregnant women
- Adults (18-64 years)
- General population
- Infants (<1 year)
- Children (1-11 years)
- Pregnant women
- Community
- Arbovirus
- Vector-borne disease
- Zika virus
- Arboviral disease
- Vector-borne disease
- Blood sample
- Urine sample
- Hair
- Saliva
- Semen
- Vaginal fluids
- Pregnant women
- Community
- Arbovirus
- Vector-borne disease
- Zika virus
- Venezuelan equine encephalitis virus
- Arboviral disease
- Vector-borne disease
- Pregnant women
- Hospital
- Arbovirus
- Dengue virus
- Vector-borne disease
- Arboviral disease
- Vector-borne disease
- Adults (18-64 years)
- General population
- Pregnant women
- Community
- Chlamydia trachomatis
- Sexually transmitted infection
- Adults (18-64 years)
- General population
- Pregnant women
- Hospital
- Outpatient clinic
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Sexually transmitted infection